Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
AEGR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.67%35.960.8%$761.43m
JNJJohnson & Johnson
0.42%123.430.6%$757.26m
ABBVAbbVie, Inc.
-0.60%105.592.1%$745.12m
MRKMerck & Co., Inc.
1.20%59.150.6%$601.85m
BMYBristol-Myers Squibb Company
0.29%52.491.4%$456.26m
LLYEli Lilly and Company
0.54%82.661.0%$343.59m
AZNAstraZeneca PLC Sponsored ADR
-0.54%36.851.3%$160.93m
NVSNovartis AG Sponsored ADR
-0.57%76.400.2%$109.74m
GSKGlaxoSmithKline plc Sponsored ADR
-0.37%40.180.2%$109.37m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.74%48.260.1%$74.48m
SNYSanofi Sponsored ADR
-0.84%38.610.2%$43.01m
LCILannett Company, Inc.
-0.15%16.7337.9%$13.44m
EPIXESSA Pharma Inc
-2.13%3.210.0%$0.17m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.19%1.831.7%$0.11m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.